metatools
SDTM supplemental-qualifier merging got sturdier, then the package went quiet for two years.
Comparison · Analytics
nanonext vs pharmaversesdtm
A side-by-side editorial comparison of nanonext and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.
nanonext vs pharmaversesdtm: at a glance
What is nanonext?
nanonext keeps shrinking its build requirements while adding messaging primitives.
The R binding to NNG ships roughly monthly. Since February the package added an HTTP server that can run synchronously or through the later event loop, a zero-copy device forwarder for building brokers and proxies, and support for pthread-enabled WebAssembly targets. Send operations now move the buffer straight into the NNG message, halving peak memory on serialized sends.
What is pharmaversesdtm?
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
nanonext vs pharmaversesdtm: editorial side-by-side
nanonext
2.5ANALYTICS
nanonext keeps shrinking its build requirements while adding messaging primitives.
◆ Current state
The R binding to NNG ships roughly monthly. Since February the package added an HTTP server that can run synchronously or through the later event loop, a zero-copy device forwarder for building brokers and proxies, and support for pthread-enabled WebAssembly targets. Send operations now move the buffer straight into the NNG message, halving peak memory on serialized sends.
◆ Where it's heading
Two directions run in parallel. One is making the package installable anywhere — the build-time cmake dependency is gone, so compiling bundled NNG and Mbed TLS needs only a C compiler, and WebAssembly targets are supported. The other is raising the ceiling on what can be built on top: device_aio() for message forwarding, an HTTP and WebSocket server with a content map, and stream buffer control. Bug fixes in recent releases concentrate on memory safety in the bundled C sources.
◆ Prediction
Given the pace and the tight coupling declared in each release, expect the next version to track a mirai requirement and continue hardening the HTTP server paths that the last two releases have been leaking memory in.
pharmaversesdtm
0.0ANALYTICS
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
◆ Current state
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
◆ Where it's heading
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
◆ Prediction
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
Alternatives to nanonext and pharmaversesdtm
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either nanonext or pharmaversesdtm.
marquee
marquee is filling in the typographic details — outlines, border types, real font metrics for underlines.
logrx
A clinical-script logger that stopped shipping after its 0.2 line, changelogs made of merged PRs.
lobstr
R's object inspector is losing its view of the internals as CRAN closes off the private C API.
GSODR
A weather-station data client that broke one return type to hand back distances instead of bare IDs.
giscoR
giscoR's 1.0 moved its dataset index into the cache, so new Eurostat releases arrive without a package update.
See all nanonext alternatives → · See all pharmaversesdtm alternatives →
Recent activity from nanonext and pharmaversesdtm
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 9d agonanonextMemory leaks and a TLS use-after-free fixed in the HTTP server
- 1mo agonanonextEvent-loop integration for HTTP and WebSocket callbacks
- 1mo agonanonextZero-copy message forwarding, and cmake dropped from the build ⚡
- 1mo agopharmaversesdtmLymphoma response data and geographic-atrophy tests
- 2mo agonanonextBuilds against pthread-enabled WebAssembly targets
- 3mo agonanonextSerialized sends drop a copy and halve peak memory
- 4mo agonanonextBlocking HTTP server mode and stream buffer sizing
- 4mo agopharmaversesdtmCSV exports and microbiology domains for wider access
- 7mo agopharmaversesdtmNeurological SDTM datasets and Alzheimer's biomarkers
- 11mo agopharmaversesdtmMaintainer and licensing update
- 1y agopharmaversesdtmMetabolic SDTM datasets and PCWG3 oncology response
- 1y agopharmaversesdtmGCIG response data and automated reference pages
Frequently asked questions
What is the difference between nanonext and pharmaversesdtm?
They serve adjacent needs but don't currently overlap on shipped themes. nanonext is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is nanonext better than pharmaversesdtm?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. nanonext is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to nanonext?
Top nanonext alternatives in Analytics are ranked by recent ship velocity. Browse the "nanonext alternatives" section above for the current picks, or visit /alternatives/nanonext for the full list with editorial commentary on each.
What are the best alternatives to pharmaversesdtm?
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.